Ravi Kota, Chief Secretary of Assam, announced that Sun Pharmaceutical will be investing ₹500 crore to set up a manufacturing plant in Assam. The plant in question, as per Kota, will generate employment for over 500 people.
“Held a meeting with representatives of Sun Pharmaceutical Industries Limited… to review the company’s proposal for setting up pharmaceutical manufacturing facilities in Assam,” Kota shared in a post on X.
Held a meeting with representatives of Sun Pharmaceutical Industries Limited today, including Shri Rahul Awasthi, Senior Vice President, and Shri Ranjit Mohapatra, Associate Vice President, to review the company’s proposal for setting up pharmaceutical manufacturing facilities in… pic.twitter.com/hOfaHrnD5J
— Chief Secretary, Assam (@CSAssam_) February 4, 2026
“The proposal involves establishing drug formulation manufacturing units in the State to cater to the Indian market, with a planned investment of over ₹500 crore to be implemented in two phases,” Kota added. “The project is expected to generate direct employment for more than 500 persons in a phased manner after commencement of operations.”
In the meeting, Kota and officials like Shri Rahul Awasthi, Senior Vice President, and Shri Ranjit Mohapatra, Associate Vice President, discussed aspects such as land requirements, availability of water and power, connectivity, and access to skilled manpower.
Sun Pharma also emphasises its focus on sustainable manufacturing practices. This includes efficient water use, increased adoption of renewable energy, and responsible waste management, in line with environmental and regulatory standards.
The meeting and the deal with Sun Pharma were, as per Kota, part of the state government’s ongoing engagement with prospective investors to promote employment generation, inclusive development, and long-term economic growth in the State.
